Get started
ARROWHEAD PHDRNARROWHEAD PHDRNARROWHEAD PHDRN

ARROWHEAD PHDRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

A2RR34 chart


Full chart

Key stats


Market capitalization
‪9.52 B‬ BRL
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.003 BRL
Net income (FY)
‪−3.10 B‬ BRL
Revenue (FY)
‪18.36 M‬ BRL
Shares float
—
Beta (1Y)
−0.17

About Arrowhead Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher Richard Anzalone
Website
arrowheadpharma.com
Headquarters
Pasadena
Founded
1989
ISIN
BRA2RRBDR009
FIGI
BBG014XHR9H9
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

A2RR34 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as A2RR34.